Can Ivosidenib be stopped once you start taking it?

Ivosidenib is an oral small molecule inhibitor that targets IDH1 mutations. It is mainly used to treat acute myeloid leukemia (AML) and some patients with solid tumors who have IDH1 mutations. In actual treatment, it does not mean that "once you take the drug, you cannot stop it." However, whether to stop the drug needs to be comprehensively decided based on the specific treatment response, side effects, and doctor's evaluation. Medication cannot be interrupted or extended without authorization.

The treatment cycle of ivonib is usually long, especially in patients with acute myeloid leukemia, who often need to take it continuously for several months or even longer to observe an obvious therapeutic response. Studies have shown that some patients experience remission after 3 to 6 months of treatment, so doctors often recommend continued medication to maintain efficacy. However, if the patient's condition is in remission and stable, the doctor may consider whether to continue maintenance treatment or make adjustments based on individual circumstances.

In some cases, if patients experience serious adverse reactions (such as QT prolongation, abnormal liver function, etc.) or drug resistance, doctors may recommend suspending, reducing the dose, or completely discontinuing ivonib. This decision must be based on regular blood, electrocardiogram, and liver and kidney function monitoring results. Unauthorized discontinuation of medication may lead to disease progression, especially when the disease is not under control.

Whether to discontinue ivosidenib should be evaluated and made by a professional hematologist or oncologist. Even if the condition is relieved, the medication cannot be stopped or the treatment cycle is interrupted at will, and an individualized treatment plan should be followed. Patients should maintain good compliance during the medication period, return for follow-up appointments on time, and provide timely feedback on any discomfort so that the doctor can make adjustments based on the treatment response. In short, Avonib is not "once you start taking it, you can never stop it", but it does need to be managed under the guidance of a doctor.

Reference link:https://www.tibsovo.com/